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Abstract 
The cAMP pathway is major signal transduction system involved in hippocampal 
neurotransmission. Recently, the peptide somatostatin-14 (SRIF) has emerged as a key signal that, 
by activating its receptors, inhibits epileptiform bursting in the mouse hippocampus. Little is known 
on transduction mechanisms which may mediate SRIF function in native cell/tissues. Using a well 
established model of epileptiform activity induced by Mg2+-free medium with 4-aminopyridine (0 
Mg2+⁄4-AP) in mouse hippocampal slices, we demonstrated that PKA-related signaling is 
upregulated by hippocampal bursting and that treatment with SRIF normalizes this upregulation. 
We also demonstrated that the SRIF-induced inhibition of PKA impairs phosphorylation of the
NMDA receptor subunit NR1. Extracellular recordings of the 0 Mg2+⁄4-AP-induced hippocampal 
discharge from the CA3 region demonstrated that treating slices with compounds which interfere 
with PKA activity prevent SRIF inhibition of epileptiform bursting. Our results suggest that SRIF 
modulation of hippocampal activity may involve PKA-related signaling.
Key words: transduction pathway, epilepsy, hippocampal slices, PKA modulation,
electrophysiological recordings 
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Introduction
A major signal transduction system which is related at various levels with hippocampal 
neurotransmission is the adenylyl cyclase (AC)/cyclic AMP (cAMP)/ cAMP-dependent protein 
kinase A (PKA) pathway (see for review Nguyen and Woo 2003). The cAMP signaling system is 
regulated by hippocampal seizures (Higashima et al. 2002; Iwasa et al. 2000; Jang et al. 2001), and 
changes in PKA phosphorylation of glutamate receptors have been found to be related to epileptic 
seizures in the rat hippocampus (Arias et al. 2002; Chang et al. 2005; Huo et al. 2006; Moussa et al. 
2001; Niimura et al. 2005). On the other hand, there is evidence that the PKA pathway plays a role
in the control of glutamatergic and GABAergic transmission in the rat hippocampus (Negrete-Diaz 
et al. 2006; Pita-Almenar et al. 2006; Poisbeau et al. 1999), while cAMP has been shown to mediate 
epileptiform generation in rat hippocampal slices (Higashima et al. 2002). The possibility that the 
PKA pathway may affect the epileptic state is further strengthened by the finding that inhibition of 
the PKA activity may display an antiepileptic effect (Vazquez-Lopez et al. 2005).
The peptide somatostatin-14 or SRIF (somatotropin release inhibiting factor) is widely distributed 
in the mammalian brain where it mediates numerous functions through binding to its receptors (sst1-
sst5), all belonging to the G protein-coupled receptor family (se  for review Hannon et al. 2002; 
Olias et al. 2004). Beside their initially described neuroendocrine role, SRIF systems have been 
shown to subserve neuromodulatory roles in the brain, influencing motor activity, sleep, sensory 
processes and cognitive functions, and are altered in brain diseases like affective disorders, 
Alzheimer's disease and epilepsy (see for review Cervia and Bagnoli 2007; Viollet et al. 2008). In 
this respect, numerous evidence suggests that SRIF is a potent endogenous anticonvulsant (see for 
review Tallent and Qiu 2008). In particular, functional data on the hippocampal SRIF system of 
rodents have provided compelling evidence that SRIF compounds play an important role in 
inhibiting excitatory transmission, including hyperexcitability underlying seizures (Binaschi et al. 
2003; Fu and van den Pol 2007; Tallent and Siggins 1999; Vezzani and Hoyer 1999). In this 
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respect, SRIF inhibitory effects on hippocampal bursting has been recently demonstrated in mouse 
hippocampal slices in a well-established model of interictal-like activity in mouse hippocampal 
slices (Cammalleri et al. 2004, 2006; Cervia et al. 2005; Ristori et al. 2008a).
Many transduction mechanisms have been described to mediate SRIF function in transfected 
systems (see for review Lahlou et al. 2004; Olias et al. 2004), however most physiological actions 
of the native SRIF receptors in situ remain to be established. There is recent evidence that the 
cyclooxygenase-2 (COX-2)/prostaglandin E2 (PGE2) pathway is involved in the SRIF-induced 
decrease of epileptiform bursting in the mouse hippocampus (Ristori et al. 2008a). An important 
component in SRIF transduction mechanisms in recombinant systems as well as in native cells/tissues 
is the modulation of the PKA pathway (see for ref. Cervia and Bagnoli 2007; Cervia et al. 2005). In 
particular, inhibition of AC by SRIF has been demonstrated in ovine and mouse retinas, in the rat 
frontoparietal cortex and in the rat hippocampus (Colas et al. 1992; Izquierdo-Claros et al. 2002, 
2004; Ristori et al. 2008b). Recently, SRIF-mediated inhibition of AC activity has been shown to 
parallel SRIF-induced reduction of epileptiform bursting in the mouse hippocampus (Cammalleri et 
al. 2006). Whether SRIF inhibition of hippocampal bursting may involve the cAMP-PKA signaling 
cascade remains to be established. 
In the present study, we have used a well-established model of pileptiform bursting in rat and 
mouse hippocampal slices (Cammalleri et al. 2004, 2006; Kilb et al. 2007; Ristori et al. 2008a; 
Sanna et al. 2000; Siniscalchi et al. 1997) in order to investigate whether SRIF inhibition of 
hippocampal discharge involves modulation of the PKA pathway.
Methods
Animals
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Experiments were performed on 84 mice (C57BL/6 strain) of both sexes at 6-8 weeks after birth 
(18-25 g body weight). Animals were kept in a regulated environment (23±1°C, 50±5% humidity) 
with a 12 h light/dark cycle (lights on at 8 a.m.) with food and water ad lib. In all experiments, mice 
were anesthetized with halothane (4%). Experiments were performed in compliance with the Italian 
law on animal care N° 116/1992 and in accordance with the European Community Council 
Directive (EEC/609/86). All efforts were made to reduce both animal suffering and the number of 
animals used.
Preparation of hippocampal slices
Slices of dorsal hippocampus were prepared as previously described (Cammalleri et al. 2004, 2006; 
Cervia et al. 2005; Ristori et al. 2008a). Mice were anaesthetized and decapitated. Their brains were 
rapidly removed, placed in ice-cold artificial cerebrospinal fluid (aCSF; 130 mM NaCl, 3.5 mM 
KCl, 1.25 mM NaH2PO4, 1.5 mM MgSO4 7H2O, 2 mM CaCl2 2H2O, 24 mM NaHCO3, 10 mM 
glucose, pH 7.4) and gassed with 95% O2 and 5% CO2. Transverse hippocampal slices (400 µm in 
thickness, 6 slices from each mouse) were prepared with the use of a vibratome (Campden 
Instruments, Loughborough, UK) and kept individually. They were incubated for 1 h at room 
temperature in aCSF. Epileptiform activity was obtained using the potassium channel blocker 4-
aminopyridine (4-AP) in the absence of external Mg2+ (0 Mg2+) (Cammalleri et al. 2004, 2006; Kilb 
et al. 2007; Ristori et al. 2008a; Sanna et al. 2000, Siniscalchi et al. 1997). In this model, 
epileptiform activity consisted of ictal discharges which disappeared within 2 h after 0 Mg2+⁄4-AP
and were replaced by continuous interictal events, which remained synchronous in the hippocampal 
regions, as previously described (Barbarosie and Avoli, 1997). This treatment has been described to 
overcome apparent discrepancies resulting from studies using either the 0 Mg2+ model or the 4-AP 
model alone (Siniscalchi et al. 1997). Slices were incubated for 3 h in either aCSF or 0 Mg2+⁄4-AP. 
Then, the medium was replaced with fresh aCSF, 0 Mg2+⁄4-AP or 0 Mg2+⁄4-AP + SRIF and the 
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slices incubated for additional 5, 10, 15 or 20 min. SRIF was used at 1 µM, a concentration giving 
maximal receptor occupancy in our system (Cammalleri et al. 2004, 2006; Cervia et al. 2005), that 
was also used in previous studies on the effects of SRIF compounds in the rodent hippocampus 
(Boehm and Betz 1997; Cammalleri et al. 2004, 2006; Ristori et al. 2008a; Schweitzer et al. 1998; 
Tallent and Siggins 1997, 1999). For measurements of AC and PKA activities, messengers and 
proteins, 3-6 samples were used for each experimental condition. Each sample consisted of 3 slices 
collected at the same anterior-posterior location from the hippocampal formation of different 
animals and pooled together. All measurements were conducted in duplicate for each sample. In 
immunohistochemical studies, 6 slices kept individually from different animals were used for each 
experimental condition. Before collection, slices were randomly evaluated electrophysiologically to 
ascertain SRIF inhibition of epileptiform activity. SRIF inhibitory effects on hippocampal bursting 
were found to be independent from slice location. In functional studies, for each experimental 
condition we used 6 slices kept individually from different animals to remove potential animal 
specific responses.
Measurements of adenylyl cyclase (AC) activity
AC activity was measured in agreement with Cammalleri et al. (2006). Briefly, slices were 
homogenized in ice-cold buffer (10 mM HEPES/Tris, 10% sucrose, pH 7.4). The homogenate was 
centrifuged at 1,000xg for 10 min, the supernatant was collected and stored. The pellet was re-
suspended, re-homogenized and centrifuged as above. The two supernatants were combined and 
centrifuged at 11,000xg for 20 min. The pellet was re-suspended in 30 mL of ice-cold buffer 
without sucrose and centrifuged at 27,000xg for 10 min. Finally, the pellet was re-suspended in the 
same buffer supplemented with 20 µg/mL aprotinin and 20 µg/mL leupeptin and used immediately. 
All steps of the above procedure were performed at 4°C. Protein concentration was determined by 
the method of Bradford (1976). The standard mixture for AC assay (0.4 mL/tube: 75 mM 
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HEPES/Tris, 1 mM EGTA, 1 mM MgSO4, 10 µM 3-isobutyl-1-methylxanthine, 500 µM GTP, pH 
7.4) was supplemented with 20 µg of membrane protein/tube. Stimulation of AC activity was 
produced by addition of increasing concentrations of Ca2+ in combination with 2 µM calmodulin.
Membranes were preincubated for 20 min at 0°C, the reaction was then initiated by the addition of 
500 µM ATP, carried out for 10 min at 30°C and stopped by boiling. After centrifugation of 
samples, cAMP was measured by a protein-binding method on the clear supernatant, using 
[3H]cAMP, according to Brown et al. (1972). The data are expressed as cAMP pmoles/min/mg of 
protein.
Measurements of mRNAs with semiquantitative reverse transcription polymerase chain reaction 
(RT-PCR)
Total RNA extraction was performed in Trizol reagent (Invitrogen, Carlsbad, CA, USA). After 
solubilization in diethyl pyrocarbonate-treated water, total RNA was quantified by SmartSpec 3000 
spectrophotometer (Bio-Rad, Hercules, CA, USA). First-strand cDNA was generated from 2 µg of 
total RNA using random primers and the reverse transcriptase of Moloney murine leukemia virus 
(Invitrogen). Forward and reverse primers were chosen from mouse sequences to hybridize to 
unique regions of the respective gene sequence and are listed in Table 1. The housekeeping gene 
cyclophilin B was used as an internal standard in agreement with previous studies in the mouse 
hippocampus (Cammalleri et al. 2004, 2006; Ristori et al. 2008a). Indeed, cyclophilin B mRNA is 
presumably stable and its hippocampal level does not appear to be influenced by epileptiform 
treatments (Cammalleri et al. 2004, 2006). The PCR reactions were carried out using 1 µl of cDNA 
in a 25 µl mixture containing 1.5 mM MgCl2, 200 µM dNTPs, and 400 nM of appropriate primers. 
Taq polymerase (0.5 U, Invitrogen) was also added. The amplification reactions were carried out in 
a thermal gradient cycler (Bio-Rad) for 25 (AC1 and cyclophilin B), 29 (AC8) or 31 (AC3 and C
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subunit of PKA) cycles. Each cycle consisted of denaturation for 60 sec at 94°C, annealing for 60 
sec and an extension for 60 sec at 72°C. The temperature of annealing was 60°C for AC1, AC8 and 
cyclophilin B, 58°C for AC3 and 55°C for C subunit. A final extension step at 72°C for 10 min 
terminated the amplification. For each amplification, two types of controls were performed: (i) RT-
PCR mixture with no reverse transcriptase to control genomic DNA contamination; and (ii) PCR 
mixture with no cDNA template added to check for possible external contamination. A 5 µl sample 
of the PCR reaction was electrophoresed on an ethidium bromide-containing 2% agarose gel. After 
migration, bands corresponding to the amplified products were analysed with Gel Doc 2000 System 
equipped with Quantity One software (Bio-Rad). Semiquantitative analysis of PCR products was 
performed by measuring the optical density (OD) of the bands corresponding to AC1, AC3 and 
AC8 isoforms or to the C subunit of PKA with respect to the OD of the band corresponding to the 
respective cyclophilin B.
Measurements of cAMP-dependent protein kinase A (PKA) activity 
Slices were homogenized in ice-cold buffer (25 mM Tris-HCl, 0.5 mM EDTA, 0.5 mM EGTA, 1 
mM DTT, 0.5 mM phenylmethylsulphonyl fluoride, 1 µg/ml leupeptin, 1 µg/ml aprotinin, pH 7.4). 
Hippocampal cytosol fraction was isolated by centrifugation at 14,000xg for 10 min at 4°C. Protein 
concentration was determined according to Bradford (1976). PKA activity was measured with the 
PepTag nonradioactive PKA assay kit (Promega, Madison, MI, USA), according to the 
manufacturer’s instructions. Briefly, PKA activity in the hippocampal cytosol fractions (10 µg 
protein/sample) was measured at 30°C for 30 min, in a mixture containing 2 µg of the PKA 
substrate kemptide and 1 µM cAMP. The reaction was stopped by placing the samples on a 95°C 
heating block for 10 min. Agarose gel electrophoresis (0.8%) was used to separate the 
phosphorylated (net charge –1) from non-phosphorylated (net charge +1) kemptide. The 
phosphorylated kemptide was excised from the gel and PKA activity was quantified 
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spectrophotometrically using a SmartSpec 3000 spectrophotometer (Bio-Rad). Data are expressed 
as incorporated picomoles of phosphate/min/mg of protein, and values represent the mean of 
duplicate determination.
Measurements of protein levels with Western blot 
To measure the protein levels of the C subunit of PKA, hippocampal extracts were prepared as 
previously described (Cammalleri et al. 2006, 2004). Briefly, the hippocampus was homogenized in 
10 mM Tris-HCl, pH 7.6 containing 5 mM EDTA, 3 mM EGTA, 250 mM sucrose, 1 mM 
phenylmethylsulphonyl fluoride, 1 µM peptistatin, 10 µg ⁄ mL leupeptin, 2 µg ⁄ mL aprotinin and 
centrifuged at 22,000xg for 30 min at 4°C. The supernatant was used for Western blot analysis. On 
the same samples, the expression of -tubulin was evaluated as an internal standard.
To measure the protein levels of the NMDA receptor (NMDAR) subunit NR1 and of its 
phosphorylated form, hippocampal extracts were prepared according to Niimura et al. (2005). 
Briefly, the hippocampus was homogenized in 0.32 M sucrose containing leupeptin, aprotinin, and 
antipain (5 µg/mL each), 0.1 mM phenylmethylsulfonyl fluoride, 0.1 mM sodium orthovanadate, 20 
mM each of -glycerophosphate and p-nitrophenylphosphate. The homogenate was centrifuged at 
22,000xg for 30 min at 4°C and the supernatant was used for Western blot analysis. Protein 
concentration in each sample was determined according to Bradford (1976).
Aliquots of each sample containing equal amounts of protein (40 µg) were subjected to 10% sodium 
dodecyl sulphate–polyacrylamide gel electrophoresis, according to Laemmli (1970), and 
transblotted onto polyvinylidene difluoride membrane. Membranes were blocked 1 h in 3% non-fat 
milk and incubated with primary antibodies. To evaluate levels of the C subunit of PKA, 
membranes were incubated overnight at 4°C with a rabbit polyclonal antibody directed against the 
C-terminus (1:200 dilution) or a goat polyclonal antibody directed against the N-terminus (1:200 
dilution) of the C subunit.  To evaluate phosphorylation of NR1 subunit of NMDA receptors by 
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PKA, we examined serine phosphorylation on the PKA phosphorylation site Ser897 (pS897 NR1). 
Membranes were incubated overnight at 4°C with a rabbit polyclonal antibody directed against 
pS897 NR1 (1:500 dilution). The membranes where then incubated for 2 hours at 4°C with 
horseradish peroxidase-linked secondary antibodies directed against rabbit IgG (1:2,500 dilution) or 
goat IgG (1:2,500 dilution), as appropriate, and developed by the enhanced chemiluminescence 
detection method (Supersignal West Pico, Pierce, Rockford, IL, USA). Subsequently, membranes
were stripped and re-probed with a rabbit polyclonal antibody directed against -tubulin (1:200 
dilution) or against NR1 subunit (1 µg/ml dilution). OD of the bands was evaluated by using 
Quantity One software (Bio-Rad). OD of C subunit was normalized to the level of -tubulin 
whereas OD of pS897 NR1 was normalized to the level of NR1.
Immunohistochemistry
Slices were fixed for 1 h in 4% paraformaldehyde in 0.1 M phosphate buffer (PB) at 4°C. They 
were then rinsed in 0.1 M PB and incubated for 48 h in 1:200 of a rabbit polyclonal antibody 
directed against the C-terminus of the C subunit of PKA diluted in 0.1 M PB containing 0.3% 
Triton X-100 at 4°C. The slices were then rinsed in 0.1 M PB and incubated overnight in secondary 
antibody conjugated with Alexa Fluor 488 at a dilution of 1:200 in 0.1 M PB containing 0.3% 
Triton X-100. Finally, the slices were rinsed in 0.1 M PB, mounted on gelatin-coated glass slides 
and coverslipped in a 0.1 M PB-glycerine mixture. The specificity of C-immunoreactivity (-ir) 
was evaluated by omitting the primary antibody. The slices were examined with a confocal laser 
scanning microscope (Leica Microsystems Heidelberg, Mannheim, Germany) using 10x or 40x 
objective lens. Optical sections were scanned through the thickness of each slice, and single 1 µm 
thick optical sections at the same predetermined z-axis were collected for the analysis of C-ir 
intensity. Methods for measuring immunofluorescence intensity from blindcoded confocal images 
were adapted from Gazzaley et al. (1996a, b; 1997) and are detailed in previous works (Cammalleri 
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et al. 2006; Ristori et al. 2008a). The software package KS-300 (Carl Zeiss Vision, München-
Hallbergmoos, Germany) was used to determine the average pixel intensity (grey scale) of single 
fields in the CA1, CA3 and in the dentate gyrus. Within each field, the contribution of unlabelled 
portions was removed, normalizing the data to the background fluorescence. Mean intensity values 
for each field were expressed as a percentage of the average fluorescence intensity of the 
corresponding field of hippocampal slices in basal conditions (aCSF). The data represent the mean 
intensity values from 6 slices for each experimental condition.
Electrophysiology
Using published protocols (Cammalleri et al.2004, 2006; Cervia et al. 2005; Ristori et al. 2008a), at 
the end of the incubation in 0 Mg2+⁄4-AP hippocampal slices were transferred to an interface 
recording chamber containing fresh 0 Mg2+⁄4-AP. They were continuously superfused at 3 ml/min 
with gassed bathing solution at 32°C; the drugs were added to this superfusion solution.
Extracellular recordings of hippocampal discharge were performed from the stratum pyramidale of 
the CA3 region by using 2-5 M microelectrodes filled with aCSF. Epileptiform bursts induced by 
0 Mg2+⁄4-AP were amplified with an Axoclamp-2B amplifier (Axon Instruments, Foster City, CA, 
USA), filtered (DC 3-10 kHz) and displayed on an oscilloscope. Signals were recorded for 20 min. 
The interval between SRIF application and the recording of an observable effect was 6-8 min. All 
traces were analysed using the LabView software package (National Instruments, Austin, TX, 
USA). The data represent the mean discharge frequency (burst frequency/min) over the registration 
period from 6 slices for each experimental condition. Inhibition of burst frequency was calculated 
as a percentage of the burst frequency in the presence of 0 Mg2+⁄4-AP.
Analysis of data
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Upon verification of normal distribution, statistical significance of data was evaluated using 
ANOVA followed by multiple comparison Bonferroni’s post-test. GraphPad Prism software 
package (Graph Software, San Diego, CA, USA) was used. Differences with P<0.05 were 
considered significant. EC50 and IC50 were determined by non-linear regression curve analysis of 
the concentration-effect responses using GraphPad Prism. Results are given as means ± SEM.
Chemicals 
SRIF was purchased from Bachem (Bubendorf, Switzerland). Primer pairs for AC1, AC3, AC8, C
and cyclophilin B were purchased from Eurobio (Les Ulis, France). [3H]cAMP (20 Ci/mmol) was 
purchased from Perkin-Elmer Life Sciences (Waltham, MA, USA). Antibodies directed against the 
C-terminus or the N-terminus of C subunit or against -tubulin as well as the horseradish 
peroxidase-linked secondary antibodies were purchased from Santa Cruz Biotechnology (Santa 
Cruz, CA, USA). Secondary antibodies conjugated with Alexa Fluor 488 were purchased from 
Molecular Probes (Eugene, OR, USA). Antibodies directed against NR1 or pS897 NR1 were from 
Upstate Biotechnology (Lake Placid, NY, USA). Where not specified, chemicals and reagents were 
obtained from Sigma-Aldrich (St. Louis, MO, USA).
Results
SRIF effects on both AC activity and expression of Ca2+-stimulated AC isoforms
In the present study, we evaluated whether SRIF inhibitory action on epileptiform bursting involves 
modulation of AC activity. AC activity in hippocampal slices was significantly higher after 0 
Mg2+⁄4-AP (136.2±15.4%, P<0.001) and this increase was diminished by SRIF, which recovered 
AC activity levels measured in aCSF conditions (Fig. 1a). The increase in intracellular Ca2+
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concentration plays a critical role in seizure etiology (DeLorenzo et al. 2006). Thus, we evaluated 
whether SRIF inhibitory action on epileptiform bursting involves modulation of Ca2+-stimulated 
AC activity. As shown in figure 1b, the effects of Ca2+ on the AC activity in hippocampal 
membranes were bidirectional, a typical trend reflecting the main involvement of Ca2+-stimulated 
AC isoforms (namely AC1, AC3 and AC8) in the hippocampal AC activity (Guillou et al. 1999). 
Maximal stimulation occurred at micromolar concentrations of Ca2+. Curve-fitting analyses 
revealed that Ca2+ produced a concentration-dependent stimulation of AC activity with an EC50
which was significantly lower in 0 Mg2+⁄4-AP than in 0 Mg2+⁄4-AP + SRIF and in aCSF (0.018 µM 
in 0 Mg2+⁄4-AP vs 0.052 µM in 0 Mg2+⁄4-AP + SRIF and 0.039 µM in aCSF, P<0.001 and P<0.05, 
respectively). No statistical differences were observed between the EC50 values of aCSF-treated 
slices and 0 Mg2+⁄4-AP + SRIF-treated slices. Changes in the catalytic properties of Ca2+-stimulated 
AC isoforms could result from alterations in the subtype of AC being expressed. We therefore 
examined whether treatment with 0 Mg2+⁄4-AP could enhance the expression of the mRNAs for the 
Ca2+-stimulated AC isoforms, and whether SRIF application could counteract this effect. As shown 
in figure 2, we found that treatment with 0 Mg2+⁄4-AP significantly increased the mRNA levels of 
AC1, AC3 and AC8 as compared to mRNA levels measured in aCSF conditions (40.4±5.5%, 
P<0.01; 49.1±6.7%, P<0.05; 45.4±3.5%, P<0.01, respectively). These increases were not influenced 
by 5, 10 or 15 min treatment with SRIF. In contrast, 20 min treatment with SRIF abolished the 0 
Mg2+/4-AP-induced increase in mRNAs of the three isoforms.
SRIF effects on both PKA activity and expression of the C subunit of PKA
PKA is the main effector of cAMP regulation, thus we may expect that variations in both AC 
activity and expression of distinct AC isoforms result in concomitant changes of PKA activity. We 
examined whether SRIF-induced decrease of both AC activity and AC isoform expression in 
hippocampal slices treated with 0 Mg2+/4-AP was accompanied by a down-stream decrease in PKA 
Page 13 of 43 Naunyn-Schmiedeberg
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
14
activity. As shown in figure 3, after 0 Mg2+⁄4-AP, PKA activity was significantly increased 
(45.8±10.6%; P<0.001). In 0 Mg2+⁄4-AP-treated slices, SRIF administration restored values of PKA 
activity similar to those observed in aCSF.
PKA is a tetrameric enzyme consisting of two regulatory and two catalytic subunits. cAMP 
promotes PKA activity by binding to regulatory subunits, thereby releasing active catalytic subunits 
including C and C both of which are expressed in the rodent hippocampus (Shobe 2002). In order 
to determine whether SRIF inhibition of epileptiform bursting influences C expression in the 
mouse hippocampus, we evaluated the effects of 0 Mg2+⁄4-AP either alone or in combination with 
SRIF on both messenger and protein of the C subunit in hippocampal slices. We found that 0 
Mg2+/4-AP treatment increased C mRNA levels by 35.7±5.2% (P<0.01) with respect to aCSF (Fig. 
4a). The 0 Mg2+/4-AP-induced increase in the mRNA level of the C subunit was not influenced by 
5 or 10 min treatment with SRIF. In contrast, 15 or 20 min treatment with SRIF abolished the 0 
Mg2+/4-AP-induced increase in C subunit mRNA level. Semiquantitative Western blot analysis of 
hippocampal lysates using antibodies directed against either the C-terminus (Fig. 4b) or the N-
terminus (Fig. 4c) of the C subunit revealed a substantial increase in levels of the C protein after 
0 Mg2+/4-AP treatment (60.7±9.0%, P<0.01 and 74.6±8.9%, P<0.01, respectively). This 0 Mg2+/4-
AP-induced increase in the C protein was abolished by SRIF when applied for 20 min but not for 
5, 10 or 15 min (Fig. 4b, c). Our immunohistochemical observations confirmed these data. In 
addition, they provided novel insights on C subunit localization in the mouse hippocampus. As 
shown by the confocal image of figure 5a, constitutive C protein expression, as detected by the use 
of an antibody directed against the C terminus of the C subunit, could be observed in many areas 
of the hippocampus. In particular, prominent staining was in the CA3 and in the dentate gyrus. As 
shown by higher magnifications (insets of Fig. 5a), in CA3 immunolabeling was in pyramidal cell 
somata and in their dendritic fields of the stratum lucidum where the mossy fiber pathway 
terminates; in the dentate gyrus immunolabeling was in granular cell somata and in the stratum 
moleculare. Less staining was observed in CA1, where it was localized in the pyramidal cell somata 
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and their dendritic field of the stratum radiatum. After 0 Mg2+⁄4-AP treatment, immunolabeling 
intensity was observed to increase in both CA3 and the dentate gyrus when compared with the basal 
condition, and this increase was abolished by SRIF (Fig. 5b, c). This was confirmed by the 
quantitative analysis showing that no effects of 0 Mg2+⁄4-AP on C-ir were found in the pyramidal 
layer of CA1 (Fig. 5d), whereas C-ir significantly increased in the pyramidal layer of CA3 
(93.1±12.6%, P<0.01, Fig. 5e) and in the molecular layer of the dentate gyrus (86.2±25.2%, P<0.05, 
Fig. 5f). SRIF completely restored C-ir in both CA3 and dentate gyrus.
SRIF effects on phosphorylation of NMDA receptors
In the hippocampus, NMDA receptors (NMDARs) are tetrameric complexes consisting of NR1, 
NR2A and/or NR2B subunits (Hawkins et al. 1999). Seizure activity is associated with enhanced 
phosphorylation of hippocampal NMDAR subunits (Arias et al. 2002; Huo et al. 2006; Moussa et 
al. 2004; Niimura et al. 2005). In particular, PKA-induced phosphorylation of NR1 has been 
demonstrated in rat hippocampal models of status epilepticus (Niimura et al. 2005). In order to 
determine whether specific NR1 phosphorylation by PKA is inhibited by SRIF in the mouse 
hippocampus, a semiquantitative Western blot analysis was performed. As shown in figure 6, after 
0 Mg2+⁄4-AP, phosphorylation of NR1 at the PKA-dependent site serine 897 was significantly 
increased (84.4±4.2%; P<0.001). SRIF administration did not alter total protein levels of NR1 
subunit of NMDAR. However, it did markedly reduce the level of NR1 phosphorylation 
(33.3±2.4%; P<0.001).
PKA involvement in the SRIF-mediated inhibition of hippocampal bursting
The cAMP cascade is one of the major second messenger systems regulating hippocampal activity 
(Arnsten et al. 2005; Nguyen and Woo 2003). Also, our observations that SRIF inhibits the 
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cAMP/PKA transducing system activated by epileptiform treatment (see above), led us to test 
whether this system was involved in the inhibition of epileptiform bursting induced by SRIF. If a 
decrease of cAMP levels is necessary for the SRIF-mediated inhibition of epileptiform bursting, 
preventing this decrease should block this effect. Therefore, in these experiments, we treated slices 
with the membrane-permeable cAMP analog dibutyryl cAMP (dbcAMP; Henion et al. 1967) that 
should “clamp” PKA activity at a high constant level. dbcAMP was used at 0.5 mM, according to 
previous works (Diogenes et al. 2004; Slack and Walsh, 1995). As shown in figure 7, interictal 
spontaneous discharges developed within 40–60 min in the CA3 region of hippocampal slices 
treated with 0 Mg2+⁄4-AP. The frequency (29.7±0.2/min) and duration (150-200 msec) of the 
discharge became stable after 2 h and did not change up to 5 h (data not shown). In agreement with 
previous results (Cammalleri et al. 2004, 2006; Cervia et al. 2005; Ristori et al. 2008a), SRIF (20 
min treatment) decreased significantly the bursting frequency by 35.6±2.1% (P<0.001). By itself, 
dbcAMP (2 h pretreatment and continuously perfused in the recording bath), did not affect the 0 
Mg2+⁄4-AP-induced bursting frequency, but in combination with SRIF (20 min treatment) it 
completely abolished the inhibitory effect of SRIF on bursting discharge. The fact that dbcAMP 
itself did not influence hippocampal activity is in agreement with previous results demonstrating 
that excitatory synaptic transmission is not influenced by dbcAMP in the rat hippocampus 
(Diogenes et al. 2004). To further test the hypothesis that the PKA pathway may mediate the action 
of SRIF on epileptiform bursting, we increased PKA activity by enhancing cAMP production 
through AC activation using forskolin. Slice incubation with forskolin (30 µM) for 1 h caused a 
58.2±2.6% (P<0.001) increase of 0 Mg2+⁄4-AP-induced hippocampal bursting. This observation is 
in agreement with previous results demonstrating that forskolin enhances afterdischarge generation 
in rat hippocampal slices (Higashima et al. 2002) and increases interictal bursting in hippocampal 
slices from neonatal mice (Agmon and Wells 2003). In forskolin-stimulated slices, the inhibitory 
action of SRIF was abolished (Fig. 7).
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In another set of experiments, we tested the effects of SRIF on bursting discharge in the presence of 
H-89, which directly inhibits the catalytic subunit of PKA. Given the large variability of H-89 
concentrations reported to inhibit PKA activity (Cunha-Reis et al. 2005; Li et al. 2007; Munno et al. 
2003; Welsby et al. 2007; Young and Yang 2004), we assessed H-89 efficacy to inhibit PKA in our 
experimental model by measuring PKA activity in 0 Mg2+/4-AP-treated hippocampal slices after 
their incubation in increasing concentrations of H-89. We found that increasing concentrations of 
H-89 produced a dose-dependent inhibition of 0 Mg2+⁄4-AP-stimulated PKA activity with an IC50 of 
0.5 µM and an Emax of 90.6% (Fig. 8a). As shown in figure 8b, by itself, 3 µM H-89 (2 h 
pretreatment and continuously perfused in the recording bath), did not affect the 0 Mg2+⁄4-AP-
induced bursting frequency in agreement with the observation that H-89 does not influence ictal 
activity in rat hippocampal slices (Higashima et al. 2002). When SRIF was applied in the presence 
of H-89, bursting discharge was not significantly different from that recorded after the application 
of 0 Mg2+⁄4-AP alone, indicating that H-89 abolished the inhibitory effect of SRIF on epileptiform 
bursting.
Discussion
There is general agreement that SRIF exerts important inhibitory actions in the hippocampus and 
acts as an endogenous antiepileptic. However, the molecular events linking SRIF receptors to their 
inhibitory effects on hippocampal bursting are poorly understood. The results of the present study 
suggest that the PKA pathway may be involved in the reduction of epileptiform bursting caused by 
SRIF in the mouse hippocampus. 
As shown by our results, SRIF counteracts the increase of AC activity and expression associated 
with epileptiform bursting. Our findings that both AC activity and the mRNA expression of distinct 
AC isoforms are increased by epileptiform treatment is in line with previous observations showing 
increased cAMP levels in seizures (see for ref. Higashima et al. 2002), increased levels of AC 
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isoform mRNAs in the hippocampus following kindling or chronic electroconvulsive shock (Iwasa 
et al. 2000; Jang et al. 2001) and involvement of increased AC expression in the onset of glutamate-
induced epilepsy in the rat hippocampus (Wang et al. 2004). Our data demonstrate that these 
epileptiform bursting-related increases of AC activity and expression are inhibited by SRIF, 
suggesting an involvement of the AC transduction pathway in mediating the SRIF anti-epileptic 
effect. This SRIF inhibition of the 0 Mg2+/4-AP -induced increase in AC activity is in line with 
previous studies demonstrating that anticonvulsant action of peptides as, for instance, galanin, is 
generally associated with inhibition of AC activity (Saar et al. 2002). In addition, anticonvulsant 
pharmacological treatments, including carbamazepine, have been demonstrated to inhibit AC 
activity as well as the downstream effects of AC activation (Chen et al. 1996).
It is difficult to determine whether the decrease of AC isoform expression following SRIF 
administration is a consequence of a direct SRIF effect at the transcriptional level or a consequence 
of the SRIF-induced reduction in bursting activity. The possibility exists that different AC isoforms 
are differently regulated by SRIF and/or bursting activity. For instance, AC3 is not directly 
regulated by Gi/Go-coupled receptors; therefore an activity-dependent regulation may be present in 
this case. On the other hand, for AC1 and AC8 regulation both SRIF- and bursting activity-based 
mechanisms may be of importance.
In the AC cascade, PKA is a major modulator of synaptic transmission likely to be involved in 
molecular and cellular events leading to epileptogenesis (see for ref. Vazquez-Lopez et al. 2005). 
Although conflicting results have been reported in different models of hippocampal seizures 
(Vazquez-Lopez et al. 2005; Yechikhov et al. 2001), our data demonstrate an increased PKA 
activity in 0 Mg2+/4-AP-treated hippocampal slices. Most importantly, we have shown that SRIF 
treatment inhibits this increase, suggesting that PKA pathway may be involved in the transduction 
of the SRIF effects on epileptiform bursting. This is in agreement with evidence reporting that
modulation of hippocampal activity by neuroactive substances may involve AC/cAMP/PKA 
pathway. For instance, positive coupling to PKA mediates the effects of vasointestinal peptide and 
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brain derived neurotrophic factor on synaptic trasmission in the rat hippocampus (Cunha-Reis et al. 
2005; Diogenes et al. 2004). In addition, elevation of PKA activity in mice underlies effects of 
corticotropin-releasing factor on hippocampal neuronal excitability (Blank et al. 2003). On the other 
hand, negative coupling to AC/cAMP/PKA pathway appears to be required for induction of long 
term depression induced by the activation of glutamate and adenosine receptors or the application of 
endocannabinoids in the rodent hippocampus (Chevaleyre et al. 2007; Santschi et al. 2006).
We have shown that both the 0 Mg2+/4-AP-induced increase and the SRIF-related decrease of PKA 
activity are paralleled by consensual changes in mRNA and protein levels of the C subunit of 
PKA. The possibility exists that post-translational changes following SRIF application may change 
epitope availability, and therefore prevent the recognition of the appropriate protein levels in 
Western blotting. This does not seem to be the case, since the same amount of C subunit was 
detected with the use of two different antibodies directed against either the C-terminus or the N-
terminus of the protein. The data of protein expression obtained with Western blot are confirmed by 
immunohistochemistry. These observations also contribute important information on C subunit 
localization in the mouse hippocampus. Indeed, the only available information is in a previous 
paper reporting C subunit expression in both the dentate gyrus and pyramidal cell layers, and C
subunit localization to the dentate gyrus (Cadd and McKnight 1989). Our findings show that 0 
Mg2+/4-AP treatment increases C-ir in both the CA3 and the dentate gyrus, but not in CA1, 
suggesting a regional specificity of the PKA signaling in the hippocampus, as also indicated, for 
instance, by the observation that long term potentiation is regulated by PKA in CA1, but not in 
CA2–3 of the mouse hippocampus (Nguyen and Woo 2003).
One way by which SRIF-induced inhibition of PKA activity may result in inhibition of epileptiform 
bursting is through reduced PKA phosphorylation of glutamatergic receptors, causing a decrease of 
postsynaptic excitatory currents with a consequent hyperpolarization of pyramidal neurons, and/or 
presynaptic modulation of glutamate release by pyramidal cells. Indeed, it has been reported that 
SRIF reduces NMDA receptor-mediated excitatory postsynaptic currents in the mouse hippocampus 
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(Tallent and Siggins 1997), whereas presynaptic SRIF receptors have been shown to mediate 
excitatory transmission in the rodent hippocampus (Boehm and Betz 1997; Cammalleri et al. 2006; 
Tallent and Siggins 1997). Consistent with this hypothesis, following 0 Mg2+/4-AP treatment, we 
have observed phosphorylation of a PKA-dependent site on NMDA receptor subunit NR1, in line 
with previous data (Niimura et al. 2005), and phosphorylation decrease in the presence of SRIF. 
Our data suggest that SRIF administration to 0 Mg2+/4-AP treated hippocampal slices may reduce 
AC isoform and/or C subunit expression acting at transcriptional level. The changes, both in 
mRNA expression and in protein levels, are detected within a 20 min time span, which is 
compatible with reported short-term regulation of PKA at both messenger and protein levels (Lee et 
al. 2008; Liu et al. 2008). Our time course experiments show that AC isoforms and C subunit 
mRNA levels are decreased by SRIF application within 10-15 minutes and that the decrease of C
subunit protein levels follows within the next 5 minutes, consistent with an effect at transcriptional 
level.
Data from our functional studies investigating SRIF effects on epileptiform bursting after 
manipulation of PKA activity can be interpreted as evidence in favor of SRIF-induced effects on 
hippocampal bursting being mediated by the PKA signal transduction pathway. However, the 
possibility exists that other, alternative mechanisms are involved. For instance, there are numerous 
indications that SRIF may reduce pyramidal cell excitability through synergistic pre- and post-
synaptic actions and, in particular, through augmentation of the voltage-sensitive M-current (Qiu et 
al. 2008). In our electrophysiological studies, we interfered with PKA activity using dbcAMP, 
forskolin or H-89. dbcAMP was used to “clamp” PKA activity at constant levels, forskolin to 
induce a continuous increase of AC activity (resulting in increased PKA activation), H-89 to inhibit 
PKA activity. In all cases, the application of the compound before SRIF administration completely 
abolished SRIF effects on epileptiform bursting. Since each of the three compounds prevents, 
although in different ways, possible modulation of PKA activity, it seems that SRIF can exert its 
effects on epileptiform bursting only in the presence of a PKA activity that can be modulated. Our 
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interpretation of these results is that SRIF functional effects on epileptic bursting are likely to be 
mediated by the PKA pathway rather than by other SRIF-related effectors (for instance, ion 
channels).
In a previous study, we demonstrated that application of exogenous PGE2 blocks SRIF inhibition of 
epileptiform bursting, indicating that the COX-2/PGE2 pathway is involved in the SRIF-induced 
decrease of epileptiform bursting in the mouse hippocampus (Ristori et al. 2008a). The present 
results provide evidence that SRIF inhibition of hippocampal bursting may also require PKA 
signaling in the mouse hippocampus, suggesting that multiple signaling actions may subserve SRIF 
inhibition of hippocampal bursting. In particular, PGE2 acts through G protein-coupled receptors 
which are linked to the AC-cAMP-PKA signaling system (Rocca 2006). For instance, the PKA 
pathway has been shown to regulate PGE2-induced modulation of hippocampal excitatory 
transmission in rat CA1 pyramidal neurons (Chen and Bazan 2005). Overall, these observations 
suggest that a cross-talk between the two signaling mechanisms activated by SRIF may exist at 
some level in the PKA pathway. 
The present results imply the coupling of SRIF receptors to a second messenger cascade involving 
regulation of PKA, although SRIF receptors mediating antiepileptic action of SRIF in the 0 Mg2+/4-
AP hippocampal model still remain to be elucidated. Indeed, scarce and controversial data have 
been produced on SRIF receptor localization in the rodent hippocampus (see for ref Viollet et al. 
2008), however there is indication that in rodents, sst2 and sst4 mediate the majority of SRIF 
antiepileptic actions, with a main role of sst2 in rat and of sst4 in mouse (see for ref Tallent and Qiu, 
2008, Qiu et al. 2008). On the other hand, a role of sst1 in mediating anticonvulsant effects of SRIF 
has been also demonstrated in the 0 Mg2+/4-AP hippocampal model by Cammalleri et al. (2004) 
although this has not been confirmed by Qiu et al. (2008).
In conclusion, we demonstrated that PKA-related signaling is upregulated in a functional model of 
hippocampal bursting and that SRIF inhibition of bursting discharge is associated to 
downregulation of the same pathway. In addition, our functional studies strongly suggest that SRIF 
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effects on epileptiform bursting require modulation of PKA activity. Together, these findings 
concur to demonstrate that SRIF coupling to cAMP signaling may mediate SRIF inhibitory effects 
on epileptiform discharge.
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Table 1 Primer pairs used for RT-PCR analysis
Gene Primer sequence
Product 
length (bp)
Gene Bank 
Accession 
No.
Ref.
Cyclophilin B
F: 5'-CCATCGTGTCATCAAGGACTTCAT-3'
R: 5'-TTGCCATCCAGCCAGGAGGTCT-3'
216 M60456
Cammalleri et al. 
2004, 2006
AC1
F: 5'-AGCTATGAGCCAATCATGGC-3'
R: 5'-GACATGAGGAAGTGCTGTGC-3'
206 AF053980 Al-Hakim et al. 2004
AC3
F: 5'-CCTGTGTGCTATCATCGTGG-3'
R: 5'-TCATCTAGGTAGTCGCAGCG-3'
753 NM 138305 Al-Hakim et al. 2004
AC8
F: 5'-TCAGTGGTGGCAGGTGTAAT-3'
R: 5'-TTTGCCTGTTGAGAGACTGG-3'
337 NM 009623
Designed by Primer3 
softwarea
PKA C
F: 5'-AGCCATACCCAATCTTGCTG -3'
R: 5'-AAGGGAAGGTTGGCGTTACT -3'
126 NM 008854
Designed by Primer3 
softwarea
a
, Rozen and Skaletsky (2000)
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Figure captions
Fig. 1 a Measurements of AC activity in hippocampal slices treated with aCSF, 0 Mg2+⁄4-AP and 0 
Mg2+⁄4-AP + 1 µM SRIF. Each histogram represents the mean ± SEM (bars). *P<0.001 vs aCSF 
(ANOVA followed by Bonferroni’s post-test). Six samples were used for each experimental 
condition. For each sample, measurements were conducted in duplicate. b Effects of increasing 
Ca2+ concentrations on AC activity of membranes from hippocampal slices treated with aCSF 
(filled dots), 0 Mg2+⁄4-AP (filled triangles) and 0 Mg2+⁄4-AP + 1 µM SRIF (filled squares). The data 
points represent the mean ± SEM (bars) of 6 samples measured in duplicate. Nine mice were used
Fig. 2 Measurements of AC1 (a), AC3 (b) and AC8 (c) mRNAs in hippocampal slices treated with 
aCSF, 0 Mg2+⁄4-AP and 0 Mg2+⁄4-AP + 1 µM SRIF. Representative RT-PCR products 
corresponding to AC isoforms or cyclophilin B (internal standard) are shown in the left panels, 
whereas the semiquantitative RT-PCR analysis is in the right panels. Each histogram represents the 
mean ± SEM (bars). Four samples were used for each experimental condition. For each sample, 
measurements were conducted in duplicate. Twelve mice were used. *P<0.05 and **P<0.01 vs 
aCSF (ANOVA followed by Bonferroni’s post-test)
Fig. 3 Measurements of PKA activity in cytosol fraction from hippocampal slices treated with 
aCSF, 0 Mg2+⁄4-AP and 0 Mg2+⁄4-AP + 1 µM SRIF. PKA activity was measured using the 
fluorescent-tagged kemptide as a phosphorylation substrate. a Representative agarose gel 
containing phosphorylated and non-phosphorylated kemptide bands. In the negative control, PKA 
activity was measured in the absence of the hippocampal cytosol fraction. b PKA activity as 
quantified spectrophotometrically from excised bands. Each histogram represents the mean ± SEM 
(bars). Three samples were used for each experimental condition. For each sample, measurements 
Page 32 of 43Naunyn-Schmiedeberg
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
33
were conducted in duplicate. Five mice were used. *P<0.001 vs aCSF (ANOVA followed by 
Bonferroni’s post-test)
Fig. 4 Measurements of messenger and proteins of the PKA subunit C in hippocampal slices 
treated with aCSF, 0 Mg2+⁄4-AP and 0 Mg2+⁄4-AP + 1 µM SRIF. a Representative RT-PCR products 
corresponding to the C subunit or cyclophilin B (internal standard) and the semiquantitative RT-
PCR analysis. Each histogram represents the mean ± SEM (bars). Samples used in this study were 
the same as in Fig. 2. For each sample, measurements were conducted in duplicate. b, c Western 
blot showing immunoreactivities for the C subunit, as detected with antibodies directed against 
either the C-terminus (in b) or the N-terminus (in c) and analysis of Western blot products 
performed by measuring the optical density (OD) of the bands corresponding to the C protein with 
respect to the OD of the band corresponding to -tubulin. The antibodies used in these studies 
labeled proteic bands at the expected molecula  weights. Each histogram represents the mean ±
SEM (bars). Three samples were used for each experimental condition. For each sample, 
measurements were conducted in duplicate. Nine mice were used. *P<0.05 and **P<0.01 vs aCSF 
(ANOVA followed by Bonferroni’s post-test)
Fig. 5 a Regional distribution of C-ir in a hippocampal slice treated with aCSF. This low 
magnification image is a reconstruction of 7 confocal optical sections acquired with a 10x objective. 
Scale bars: 300 µm for the low magnification image, 40 µm for the images in the insets. DG: 
dentate gyrus; Gr: granular layer; Mol: stratum moleculare; Mos: mossy fiber pathway in the 
stratum lucidum; Or: stratum oriens; Pyr: pyramidal layer. b, c Representative images of the 
regional distribution of C-ir in hippocampal slices treated with 0 Mg2+⁄4-AP and 0 Mg2+⁄4-AP + 1 
µM SRIF. Similar to the image in the upper panel, these images are reconstructions from multiple 
confocal optical sections. Scale bar: 300 µm. d-f Relative fluorescence intensity of C-ir in distinct 
regions of hippocampal slices under the different experimental conditions. Each histogram 
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represents the mean ± SEM (bars) of data from 6 measurements in different fields of 6 different 
slices for each experimental condition. Six mice were used. *P<0.05 and **P<0.01 vs aCSF 
(ANOVA followed by Bonferroni’s post-test)
Fig. 6 Measurements of NR1 phosphorylation in hippocampal slices treated with aCSF, 0 Mg2+/4-
AP and 0 Mg2+/4-AP + 1 µM SRIF. Western blot showing immunoreactivities, as detected with 
antibodies to either pS897 NR1 or NR1 and analysis of Western blot products performed by 
measuring the optical density (OD) of the bands corresponding to pS897 NR1 with respect to the 
OD of the bands corresponding to NR1. The antibodies used in this study labeled proteic bands at 
the expected molecular weights. Each histogram represents the mean ± SEM (bars) expressed as a 
percentage of aCSF values. Three samples were used for each experimental condition. For each 
sample, measurements were conducted in duplicate. Five mice were used. *p<0.001 vs aCSF 
(ANOVA followed by Bonferroni’s post-test)
Fig. 7 Measurements of epileptiform bursting in hippocampal slices treated with 0 Mg2+⁄4-AP in the 
absence or in the presence of 1 µM SRIF either alone or in combination with 0.5 mM dbcAMP or 
30 µM forskolin. Each histogram represents the mean ± SEM (bars) of data from 6 different slices 
for each experimental condition. *P<0.001 vs 0 Mg2+⁄4-AP (ANOVA followed by Bonferroni’s 
post-test). Eighteen mice were used. Representatives traces depicting electrophysiological
recordings of epileptiform bursting are shown in the right panel
Fig. 8 a Measurements of PKA activity in cytosol fraction from hippocampal slices treated with 0 
Mg2+/4-AP in the presence of increasing concentrations of H-89. PKA activity was measured using 
the fluorescent-tagged kemptide as a phosphorylation substrate. The data points represent the mean 
± SEM (bars) of three samples. For each sample, measurements were conducted in duplicate. Eight 
mice were used. b Measurements of epileptiform bursting in hippocampal slices treated with 0 
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Mg2+⁄4-AP in the absence or in the presence of 1 µM SRIF either alone or in combination with 3 
µM H-89. Each histogram represents the mean ± SEM (bars) of data from 6 different slices for each 
experimental condition. *P<0.001 vs 0 Mg2+⁄4-AP (ANOVA followed by Bonferroni’s post-test). 
Twelve mice were used. Representatives traces depicting electrophysiological recordings of 
epileptiform bursting are shown in the right panel
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